- Trials with a EudraCT protocol (43)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
43 result(s) found for: Cervical Spine.
Displaying page 1 of 3.
EudraCT Number: 2010-019263-11 | Sponsor Protocol Number: LTS11298 | Start Date*: 2010-07-08 | |||||||||||
Sponsor Name:sanofi-aventis Recherche & Développement | |||||||||||||
Full Title: A multicenter uncontrolled extension study evaluating the long term safety and efficacy of SAR153191 in patients with Ankylosing Spondylitis (AS) | |||||||||||||
Medical condition: Ankylosing Spondylitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) AT (Prematurely Ended) CZ (Prematurely Ended) ES (Completed) HU (Prematurely Ended) LT (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000790-31 | Sponsor Protocol Number: 2011-000790-31 | Start Date*: 2011-04-29 |
Sponsor Name:AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA | ||
Full Title: Propofol-based or Sevoflurane-based Anesthesia Induction in Patients Undergoing Fiberoptic Tracheal Intubation for Cervical Spine Surgery: Effects on Systemic Hemodynamics and Respiratory Drive- th... | ||
Medical condition: surgery for cervical myelopathy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002170-36 | Sponsor Protocol Number: 2014-002170-36 | Start Date*: 2015-02-11 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: Treatment of Cervical Spinal Cord Injury with Imatinib – a safety and feasibility study | ||
Medical condition: Cervical Spinal Cord Injury | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001146-29 | Sponsor Protocol Number: 1 | Start Date*: 2016-01-12 |
Sponsor Name:Hospital Central de la Defensa | ||
Full Title: Selective local anesthesia versus a combined medication injection with corticosteroids in degenerartive spine | ||
Medical condition: Degenerative spine pain when there are no indications for surgical treatment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001579-40 | Sponsor Protocol Number: P04440 | Start Date*: 2007-04-02 | |||||||||||
Sponsor Name:Schering-Plough France | |||||||||||||
Full Title: Study of peripheral enthesitis with ultrasonography doppler in spondyloarthropathies treated with infliximab | |||||||||||||
Medical condition: Spondyloarthropathies | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) ES (Completed) DK (Prematurely Ended) HU (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002748-27 | Sponsor Protocol Number: 0881A3-403 | Start Date*: 2007-04-13 | |||||||||||
Sponsor Name:Wyeth Pharmaceuticals France | |||||||||||||
Full Title: A Multicentre, Double-Blind, Placebo-Controlled, Randomised Study of Etanercept in the Treatment of Adult Patients with Active, Severe and Advanced Axial Ankylosing Spondylitis | |||||||||||||
Medical condition: Active, severe and advanced axial ankylosing spondylitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) DE (Completed) FR (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000241-74 | Sponsor Protocol Number: CNTO148AKS3001 | Start Date*: 2014-12-30 | |||||||||||
Sponsor Name:Janssen Biologics, BV | |||||||||||||
Full Title: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects with Active Ankylosing Spondylitis | |||||||||||||
Medical condition: Ankylosing spondylitis (AS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005377-23 | Sponsor Protocol Number: SCI-GHD-201 | Start Date*: 2012-07-18 | ||||||||||||||||
Sponsor Name:Guillem Cuatrecasas Cambra | ||||||||||||||||||
Full Title: A phase II, single-center, prospective, randomized, double-blind, parallel and placebo-controlled pilot clinical study to assess the efficacy and safety of NUTROPIN® in combination with intensive r... | ||||||||||||||||||
Medical condition: Spinal Cord Injury and Growth Hormone Deficiency | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-004994-30 | Sponsor Protocol Number: NL68837.091.21 | Start Date*: 2022-02-08 |
Sponsor Name:Roessingh | ||
Full Title: Pulmonary function and sleep related disorders during cervical admission of intrathecal baclofen in spinal cord injury; a safety study | ||
Medical condition: Spasticity in patients with spinal cord injury | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002320-34 | Sponsor Protocol Number: M01 | Start Date*: 2005-10-12 |
Sponsor Name:Charité Universitätsmedizin Berlin | ||
Full Title: Randomized controlled 12 months trial with etanercept (enbrel ®) vs. sulfasalazine followed by an open-label extension with etanercept up to week 540 in early axial spondyloarthritis with focus on ... | ||
Medical condition: The proposed study is designed to get first data on efficacy and safety of etanercept in the treatment of patients with moderate to severe early axial Spondyloarthritis (SpA) with disease duration... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-005238-76 | Sponsor Protocol Number: 2014.145 | Start Date*: 2016-01-25 |
Sponsor Name:Centro Hospitalar do Porto | ||
Full Title: Can adequacy of anesthesia depth and quality of recovery be influenced by the level of neuromuscular blockade: a randomized controlled study assessing propofol and remifentanil requirements and qua... | ||
Medical condition: Seventy patients with an ASA score of I to III, 18 to 80 years old, scheduled for routine anterior cervical spine surgery in the Centro Hospitalar do Porto will be enrolled. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: PT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-002631-33 | Sponsor Protocol Number: CAIN457A2209 | Start Date*: 2009-01-14 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: Randomized, placebo controlled, double blind, multi-center phase II proof-of-concept study to assess the efficacy of AIN457 in patients with moderate to severe ankylosing spondylitis | |||||||||||||
Medical condition: Ankylosing Spondylitis (AS), which belongs to seronegative spondyloarthropathies (SpA). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-000788-30 | Sponsor Protocol Number: 1.2022 | Start Date*: 2023-04-13 |
Sponsor Name:Uzdrowisko Kamień Pomorski S.A. | ||
Full Title: Evaluation of the effectiveness of Methocarbamol in the treatment of spasticity in people with spinal cord injury. | ||
Medical condition: | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: PL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-000982-51 | Sponsor Protocol Number: P05336 | Start Date*: 2009-07-01 | |||||||||||
Sponsor Name:Schering-Plough Research Institute, a Division of Schering Corporation | |||||||||||||
Full Title: Infliximab as First Line Therapy in Patients with Early Active Axial Spondyloarthritis Trial | |||||||||||||
Medical condition: Moderate-to-severe active axial spondyloarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) AT (Completed) BE (Completed) DE (Completed) HU (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004856-41 | Sponsor Protocol Number: CCTU0178 | Start Date*: 2020-03-19 |
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and University of Cambridge | ||
Full Title: Regeneration in Cervical Degenerative Myelopathy - a multi-centre, double-blind, randomised, placebo controlled trial assessing the efficacy of Ibudilast as an adjuvant treatment to decompressive s... | ||
Medical condition: Degenerative Cervical Myelopathy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2010-020199-45 | Sponsor Protocol Number: MOR-005 | Start Date*: 2011-06-08 | |||||||||||
Sponsor Name:BioMarin Pharmaceutical Inc. | |||||||||||||
Full Title: A Multicenter, Multinational, Extension Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients with Mucopolysaccharidosis IVA (Morquio A Syndrome) | |||||||||||||
Medical condition: Mucopolysaccharidosis Type IVA | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) IT (Completed) PT (Completed) DK (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001555-37 | Sponsor Protocol Number: CC-10004-AS-001 | Start Date*: 2012-09-04 | |||||||||||
Sponsor Name:Celgene Corporation | |||||||||||||
Full Title: A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of apremilast (CC-10004) in the treatment of active ankylosing spondyl... | |||||||||||||
Medical condition: Ankylosing spondylitis (AS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) DE (Completed) SK (Completed) NL (Completed) ES (Completed) PL (Completed) SE (Completed) CZ (Completed) AT (Completed) BG (Completed) FR (Completed) EE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000226-58 | Sponsor Protocol Number: A3921120 | Start Date*: 2018-07-12 | |||||||||||
Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: A Phase 3, Randomized, Double Blind, Placebo Controlled, Study Of The Efficacy And Safety Of Tofacitinib In Subjects With Active Ankylosing Spondylitis (AS) | |||||||||||||
Medical condition: Ankylosing spondylitis (AS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) HU (Completed) CZ (Completed) ES (Completed) AT (Prematurely Ended) GB (Completed) DE (Prematurely Ended) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021048-16 | Sponsor Protocol Number: MOR-100 | Start Date*: 2010-10-07 | |||||||||||
Sponsor Name:BioMarin Pharmaceutical Inc. | |||||||||||||
Full Title: A Multicenter, Multinational, Open-Label, Extension Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients with Mucopolysaccharidosis IVA (Morquio A Syndrome) | |||||||||||||
Medical condition: Mucopolysaccharidosis Type IVA | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001055-40 | Sponsor Protocol Number: 111-209 | Start Date*: 2020-07-29 | |||||||||||
Sponsor Name:BioMarin Pharmaceutical Inc. | |||||||||||||
Full Title: A randomized, controlled, open-label clinical trial with an open-label extension to investigate the safety of BMN 111 in infants and young children with achondroplasia at risk of requiring cervicom... | |||||||||||||
Medical condition: achondroplasia | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.